Evidence map›Paper›PMID 42555442›Full record

ArticleBioMedicine2026

Hepatoprotective evaluation of benzoylated emodin derivatives: Integrating bioinformatics and

Firdayani, Putri Hawa Syaifie, Siska Andrina Kusumastuti, Muthia Rahayu Iresha, Wirawan Adikusuma, Dhecella Winy Cintya Ningrum, Etik Mardliyati, Ayu Masyita, Ariza Yandwiputra Besari, Fathir Azzaki Iradata and 1 more

Abstract read
In one paragraph

Article in BioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

FirdayaniResearch Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.
Putri Hawa SyaifieCenter of Excellence Life Sciences, Nano Center Indonesia, Tangerang Selatan, Indonesia.
Siska Andrina KusumastutiResearch Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.
Muthia Rahayu IreshaResearch Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.
Wirawan AdikusumaResearch Center for Computing, Research Organization for Electronics and Informatics, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.
Dhecella Winy Cintya NingrumCenter of Excellence Life Sciences, Nano Center Indonesia, Tangerang Selatan, Indonesia.
Etik MardliyatiResearch Center for Nanotechnology System, National Research and Innovation Agency (BRIN), Tangerang Selatan, Indonesia.
Ayu MasyitaResearch Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.
Ariza Yandwiputra BesariResearch Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.
Fathir Azzaki IradataResearch Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.
Lucy ArianieResearch Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Raya Bogor St No 32, Cibinong, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Emodin exhibits various pharmacological activities, including hepatoprotective effects. However, its clinical application is limited by poor absorption and low oral bioavailability. This study aimed to optimize emodin through benzoylation and to assess the hepatoprotective potential of the resulting derivatives integrating bioinformatics and Methods: We conducted network pharmacology, molecular docking and molecular dynamics (MD) simulations to predict potential targets and interactions of benzoylated emodin derivatives. The derivatives were synthesized and evaluated for cytotoxicity using the MTT assay. The hepatoprotective effects were assessed Results: Network pharmacology analysis and gene expression profiling identified four major targets- Conclusion: This study provides a comprehensive evaluation of benzoylated emodin derivatives as potential hepatoprotective agents. The findings suggest that these derivatives exhibit binding affinity toward important targets related to cirrhosis, reduced toxicity to cells, and enhanced the efficacy in protecting the liver

Indexed as

EmodinHepatoprotectiveHepG2Molecular dockingMolecular dynamicsNetwork pharmacology

Identifiers

PMID42555442
PMCPMC13387400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.